Abstract
Inflammatory cell infiltration is central to healing after acute myocardial infarction (AMI). The relation of regional inflammation to edema, infarct size (IS), microvascular obstruction (MVO), intramyocardial hemorrhage (IMH), and regional and global LV function is not clear. Here we noninvasively characterized regional inflammation and contractile function in reperfused AMI in pigs using fluorine (19F) cardiovascular magnetic resonance (CMR). Adult anesthetized pigs underwent left anterior descending coronary artery instrumentation with either 90 min occlusion (n = 17) or without occlusion (sham, n = 5). After 3 days, in surviving animals a perfluorooctyl bromide nanoemulsion was infused intravenously to label monocytes/macrophages. At day 6, in vivo 1H-CMR was performed with cine, T2 and T2* weighted imaging, T2 and T1 mapping, perfusion and late gadolinium enhancement followed by 19F-CMR. Pigs were sacrificed for subsequent ex vivo scans and histology. Edema extent was 35 ± 8% and IS was 22 ± 6% of LV mass. Six of ten surviving AMI animals displayed both MVO and IMH (3.3 ± 1.6% and 1.9 ± 0.8% of LV mass). The 19F signal, reflecting the presence and density of monocytes/macrophages, was consistently smaller than edema volume or IS and not apparent in remote areas. The 19F signal-to-noise ratio (SNR) > 8 in the infarct border zone was associated with impaired remote systolic wall thickening. A whole heart value of 19F integral (19F SNR × milliliter) > 200 was related to initial LV remodeling independently of edema, IS, MVO, and IMH. Thus, 19F-CMR quantitatively characterizes regional inflammation after AMI and its relation to edema, IS, MVO, IMH and regional and global LV function and remodeling.
Supplementary Information
The online version contains supplementary material available at 10.1007/s00395-022-00928-5.
Keywords: Cardiovascular magnetic resonance, Inflammation, Large animal models, Monocytes/macrophages, Myocardial infarction
Introduction
Acute myocardial infarction (AMI) and ischemic heart disease remain the leading causes of death and heart failure [43]. All-cause mortality and rehospitalization for heart failure within 1 year after AMI are critically dependent on infarct size (IS) [36]. Microvascular obstruction (MVO) and intramyocardial hemorrhage (IMH), two major features of myocardial reperfusion injury [15, 16], are of additional value in the prediction of late adverse regional and global left ventricular (LV) remodeling and mortality [6, 25, 29]. The processes of evolving edema, infarction, MVO, and IMH in reperfused AMI are dynamic and interact with inflammatory infiltration and the initiation of healing and repair [9, 19]; the repair relies on immune cell recruitment, most importantly monocytes and derived macrophages [37]. Monocytes/macrophages are attracted to the infarcted myocardium in a time- and region-dependent manner, as evidenced by histology in human myocardium [42]. Whereas inflammation is necessary for healing and repair, excessive inflammation is detrimental [14], and therapeutic modulation of inflammation after AMI might reduce patient morbidity and mortality [12, 38]. Multiparametric 1H-based cardiovascular magnetic resonance (1H-CMR) has become the gold standard for the noninvasive assessment of IS, MVO, IMH, and LV function after AMI [19]. However, there is an unmet need to visualize and quantify the spatial and temporal cellular inflammatory patterns in vivo.
Using experimental high-field (9.4 T) CMR, we established fluorine (19F)-CMR to monitor monocytes/macrophages in mouse models [10]. 19F MRI noninvasively monitors specifically infiltrating monocytes due to their rapid and specific uptake of intravenously applied perfluorocarbon nanoemulsions [3, 26]. Recently, we have demonstrated the technical feasibility of this 19F-CMR approach also in clinical scanners (i.e. field strength of 3 T) [4, 33]. In the present study, we adapted this approach to a pig model of reperfused AMI which permits a spatially resolved regional analysis of inflammatory infiltration and its relation to edema, IS, MVO, IMH as well its impact on regional and global LV contractile function.
Material and methods
Reperfused acute myocardial infarction in pigs
Experiments were performed in 22 adult female Aachen minipigs [27] with a mean body weight of 67 ± 9 kg, in accordance with the national guidelines on animal care and approval by the ‘Landesamt für Natur, Umwelt- und Verbraucherschutz’ (L84-02.04.2013.A437 and L84-02.04.2016.A322). The experimental protocol is displayed in Fig. 1. Myocardial infarction was induced in pentobarbital-isoflurane-anesthetized closed-chest pigs by 90 min of pressure-wire-controlled left anterior descending (LAD) coronary artery occlusion [33], for details see supplemental material & methods and supplemental Figure I. In 5 sham animals the LAD was instrumented but not subjected to balloon occlusion.
Production, quality control and application of perfluorooctyl bromide nanoemulsion
The perfluorooctyl bromide nanoemulsion (PFOB) was produced according to established protocols [4, 33]. A detailed description of the production, quality control, stability assessment, blood kinetics and phagocytosis of PFOB is provided in the supplemental Figures II and III. PFOB was infused intravenously on day 3 after AMI with 5 ml/kg body weight and a rate of 80 ml/h (Fig. 1) in all surviving animals (n = 10 AMI and n = 5 sham) according to previous protocols [4].
1H and 19F cardiovascular magnetic resonance data acquisition and histology
After proof of LAD patency 6 days after AMI by invasive angiography, CMR was performed using a whole-body 3.0-T Achieva X-series MR scanner (Philips Healthcare, Best, the Netherlands). In vivo CMR was performed according to previously established workflows and protocols for local signal precision with optimized 19F sequences [33]. The 1H and 19F-sequence protocols and details are reported in supplemental Table I. After in vivo 1H- and 19F-CMR acquisitions, the pigs were euthanized inside the scanner for in situ imaging with arrested hearts. Autopsy was performed, and organs (heart, liver, spleen and sternum) were explanted and stored in 4% paraformaldehyde (PFA) for analysis of histopathology and distribution of PFOB with high resolution 19F-CMR. A detailed description of the histopathological protocols and analysis, including the immunohistochemistry of TNFα, is provided in the supplemental material & methods and supplemental figure IV and V.
Cardiovascular magnetic resonance data analysis
Dedicated software (Circle CVI 42, Circle Cardiovascular Imaging Inc., Calgary, AB, Canada) was used for full automatic delineation of ventricular contours, automatic calculation of volumes and analysis of parametric T1 and T2 maps. Due to misalignment of the automated contouring algorithm, significant manual correction of endocardial contours was necessary in 3/10 pigs after AMI. As described in detail in supplemental material & methods and shown in supplemental figure VI, volumes were indexed to body weight to measure end diastolic volume index (EDVi), end systolic volume index (ESVi), stroke volume index (SVi), cardiac index (CI) as well as ejection fraction (EF), global longitudinal strain (GLS), and early longitudinal diastolic strain rate (SRe) [34]. The sphericity volume index (ShVi) was calculated with EDV/ ((π/6) * L)3 [1]. Initial remodeling was defined as > 20% EDVi increase compared to the EDVi of sham-instrumented animals, adapted from studies investigating long-term remodeling after AMI [41]. T2 weighted images and T2 maps were analyzed for the extent of myocardial edema and expressed as % of LV mass or in absolute mass (g). T2* weighted images were analyzed for IMH and expressed as % of LV mass or in milliliters (ml). Contrast-enhanced images were analyzed at first pass for myocardial perfusion and late gadolinium enhancement (LGE) after 10 min for IS (> 5 SD threshold), border zone (BZ) (> 2 < 5 SD threshold) [20] and after 15 min for MVO and expressed as % of LV mass or in milliliters (ml) [34]. Volumes containing 19F signals were quantified using the 3D visualization software Amira 4.0 (ThermoFisher Scientific,Waltham,USA), and image fusion of 1H/19F-datasets was performed with HOROS (Nimble Co LLC,USA). The fused images of all 10 animals which were included in the final analysis are shown in the supplemental figure VII. For quantification of 19F-signals, the primary signal in a respective region was corrected according to the coil sensitivity profile as outlined in supplemental figure VIII. The signal-to-noise-ratio (SNR) of respective regions was calculated from the ratio of the signal intensity mean of a region-of-interest (ROI) and the standard deviation of a background-noise ROI in the same slice located out of the thorax at comparable coil distance. 19F volumes were calculated by applying background subtraction with SNR 7, which was sufficient to subtract all unspecific technical background signals (outside the body). The 19F-integral was the product of SNR and volume.
Statistical analysis
Statistical analysis was performed using SPSS software (version 24.0, IBM, Armonk, NY, US). Unless otherwise stated, continuous variables are presented as the mean ± standard deviation (SD). Differences between the two groups (sham and AMI) were analyzed by Student’s 2-sided unpaired t test for normally distributed data and Mann–Whitney U test for non-normally distributed data. Pearson’s or Spearman’s correlation were used to assess the relationships between different CMR parameters. Separate linear regression models in pairwise combination with edema, IS, MVO, and IMH were created to adjust the univariate correlations of 19F with LV function and volumes for these parameters to test whether 19F would independently predict LV function and geometry. ROC analysis was used to identify optimal cut-off values for prediction of initial remodeling (> 20% EDVi increase compared to the sham animals mean) (AUC 0.87) or impaired remote systolic wall thickening (< cohort median of diastolic wall thickening) (AUC 0.78). The respective p values are reported in the figures.
Results
Acute myocardial infarction and safety of perfluorooctyl bromide nanoemulsion
Twenty-two pigs were included in the study. Baseline and procedural characteristics of sham pigs (n = 5), AMI survivors (n = 10) and AMI non-survivors (n = 7) are reported in supplemental Tables II and III. There were no differences in baseline characteristics between survivors and non-survivors. The cause of death (n = 7) was ventricular fibrillation refractory to defibrillation in all pigs. No pig died beyond 90 min of ischemia. There was no serious adverse side reaction when pigs received PFOB on day 3 after AMI (supplemental Table IV). The blood kinetics of PFOB are given in supplemental Figure III and revealed an almost complete clearance from the circulation 3 days after injection. Ten pigs had a patent LAD on day 6 after AMI on coronary angiography and were included in the CMR study.
LV function and initial remodeling early after AMI
Edema extent was 35 ± 8% of LV mass and IS was 22 ± 6% of LV mass. Six of 10 surviving pigs had MVO (3.3 ± 1.6% of LV mass), and the same animals also had IMH (1.9 ± 0.8% of LV mass). Figure 2 shows systemic hemodynamic, volumetric and functional data 6 days after AMI. Compared to sham pigs, pigs with AMI had a slight increase in heart rate, a trend toward lower arterial pressure and higher systemic vascular resistance. SVi, CO, EF and LGE were reduced; ESVi, EDVi and ShVi were increased. Thus, the present model provided robust infarction with early LV dysfunction and initial remodeling of varying inter-individual severity.
19F monocyte/macrophage signals co-register with the infarct area
The average acquisition time of the 3D-whole heart 19F-information was 18 ± 2 min. Figure 3 displays the correlation of local 19F-signal intensity and monocyte/macrophage density. 19F-signals were restricted to infarcted tissue and its border zone, as delineated by infarct size imaging with LGE, while remote myocardial areas displayed no 19F-signal (Fig. 3A, left). The colocalization of the 19F-label with monocytes/macrophages was confirmed by histology (Fig. 3A, right and B). The infarct area displayed patchy infiltration with monocytes/macrophages, mirrored by the respective local 19F signals. An equal number of M1 (CD68high CD163 low) and M2 (CD68low CD163high) macrophages was present within the areas of 19F signal (supplemental Figure V). The mean 19F-signal intensity was quantified considering the coil sensitivity profile (supplemental Figure VIII) and expressed as myocardial 19F-SNR. The calculated local mean 19F SNR acquired in vivo correlated with the mean monocyte/macrophage density determined by histology (Fig. 3C; R2 = 0.6075, p < 0.0001). The individual localization of the analyzed regions of interest is given in the supplemental Table V. The 19F detection threshold was 70,000 cells/mm3. In sham pigs, no myocardial 19F signal was observed, and immunohistochemistry did not show signs of acute myocardial inflammation.
Figure 4 shows the individual whole heart quantitative 19F-analysis of all surviving pigs. For inter-individual image comparison, 19F-signals of all 10 pigs are shown in supplemental Figure VII. The monocyte-dependent 19F-signals were also observed in the bone marrow of the sternum and ribs (Fig. 4A and supplemental Figure IX). These signals could easily be distinguished from AMI signals and did not disturb the signal quality or quantification. After cardiac segmentation, the average volume covered by 19F-signals per heart was 15.8 ± 9.5 ml, and it was always within and smaller than the respective individual edema extent (31.3 ± 8.7 ml) (Fig. 4A, B) and IS (20.9 ± 6.5 ml) (Fig. 4A, C). The mean myocardial 19F SNR was 13.3 ± 4.7 with a considerable inter-individual and segment-wise variation. As shown in Fig. 4D, there was a correlation of 19F-SNR with 1H derived T1 and T2 times taken from the infarcted segments of all pigs. Along with the systemic inflammatory response, we identified a correlation (R2 = 0.66) of the individual increase in circulating leukocytes from baseline until day 3 and the 19F integral (supplemental Figure III D).
Segmental 19F- and 1H-CMR-derived infarct tissue characteristics
As shown in Fig. 5A + B, not all myocardial segments with edema and infarction were positive for the 19F-CMR derived monocytes/macrophages signals. The correlation of edema extent and IS with the 19F-integral was only fair. Pigs with high 19F integral displayed only minor volume of MVO with concomitant IMH (Fig. 5 D + E). Apparently, the 19F-CMR derived monocytes/macrophages signal was of patchy nature with only fair correlation to edema extent or IS, and the 19F integral was reduced in pigs with MVO and IMH. As shown in the supplemental figure X, hemorrhage itself had no impact on 19F SNR.
Association of border zone 19F-signal with remote myocardial contractile function and initial ventricular remodeling
As shown in Fig. 6A, regional wall thickening displayed a gradient from infarct core to remote myocardium, while 19F SNR decreased in most pigs from infarct core to remote myocardium. Interestingly, the 19F-signal in the infarct border zone correlated inversely with the neighboring remote myocardial wall thickening (Fig. 6B). Histological analysis revealed significant TNF-α signals in remote cardiomyocytes of those pigs with high border zone 19F SNR (6F + 6G). Increased 19F-integrals over the entire heart correlated with enlarged EDVi and ShVi in univariate analysis. Even when adjusted for edema, IS, MVO and IMH, respectively, in multivariate models, the macrophage/monocyte derived 19F-signal was independently associated with initial LV remodeling (supplemental Table VI).
As demonstrated in Fig. 7, a cut-off 19F-integral value of 200 combined with a border zone SNR > 8 predicted impairment of remote myocardial contractile function and LV remodeling on day 6 after AMI. Pigs with whole heart 19F-integral > 200 and border zone SNR > 8 (n = 5) had less remote myocardial systolic wall thickening (29.4 ± 6 vs. 59 ± 16%, p = 0.005), larger EDVi (1.4 ± 0.1 vs. 1.0 ± 0.1 ml/kg body weight, p = 0.005) and larger ShVi (0.7 ± 0.1 vs. 0.4 ± 0.1, p = 0.005) than pigs with whole heart 19F-integral < 200 and border zone SNR < 8 (n = 5).
Discussion
In the present study using a pig model of reperfused AMI, 19F-CMR noninvasively provided quantitative information about regional inflammatory infiltration of monocytes/ macrophages early after AMI and its association with LV contractile function and geometry. Inflammatory infiltration in the infarct border zone correlated with impaired remote myocardial systolic wall thickening and initial LV remodeling. The inflammatory signal over the entire heart correlated to impaired LV contractile function and remodeling independently of myocardial edema, IS, MVO, and IMH.
In vivo imaging of monocytes/macrophages with 19F-CMR
Our preliminary experiments were conducted to test and prove the applicability of various components and processes necessary for the planning, initiation and conduction of the present study. First, we tested optimal 19F containing nanoemulsions with respect to safety, dose and timing of the emulsion administration [4]. 19F measurements were done in explanted hearts to assure easy and sufficient 19F signal acquisition [4]. Thereafter, we tested and improved the in vivo CMR approach-applicability with 19F signal distance > factor 100 compared to explanted hearts and respiratory as well as cardiac movement [33]. After these experiments, it was clear, that a bFFE sequence with an off-set frequency of 58 ppm would be the best compromise for signal precision and SNR [33].
The findings of these preliminary studies (dose, timing, optimized sequences, work flows) were necessary to efficiently conduct the present study. The specific novelty of the present approach is the comparison of state-of-the-art CMR tissue markers as well as local and global myocardial function after AMI with the in vivo 19F signal, which was also validated by histology.
Since 19F-CMR is essentially background-free, perfluorocarbon nanoemulsions are the primary source of the 19F-signal, and they are preferentially taken up by monocytes/macrophages [3, 26]. In the present study, the nanoemulsion was administered on day 3 after AMI to allow for sufficient uptake into monocytes/macrophages [26] and to induce a maximum monocyte/macrophage signal in the injured myocardium on day 6 after the insult. Untargeted perfluorocarbon nanoemulsions are taken up by M1 and M2 tissue macrophages to an equal extent [13]. Since both cell types were present in equal numbers in our study on day 6 after reperfused AMI, the 19F-signal observed reflected most likely a mixture of a M1 and a M2 macrophage infiltration. Additionally, the 19F-signal was closely associated with altered tissue relaxation properties indicating early tissue reorganization in infarcted myocardium with a high volume and density of monocytes/macrophages.
As an alternative to 19F labeling of immune cells, ultrasmall iron oxide nanoparticles (USPIOs) enhanced 1H-based CMR has been used. USPIOs also preferentially label monocytes/macrophages and significantly affect 1H relaxation properties. This technique, leading to signal voids in the area of monocytes/macrophages, has provided initial, promising diagnostic results in patients after AMI, but its specificity has been hampered by interference with IMH [29, 46]. Beyond direct visualization of immune cells, the metabolic signature of inflammation can be assessed with positron-emission tomography (PET) or hyperpolarized CMR [23, 24, 31, 32].
PET MRI using 18F-fluorodeoxyglucose (18F-FDG) has proven significant value in the detection of atherosclerosis-related inflammation and in predicting restenosis in peripheral artery disease [5, 8]. There are specific nuclear PET tracers for imaging monocytes/macrophages after AMI [30, 31, 39]. Indeed, combined PET-MRI approaches have identified certain cell types and inflammatory activity using optimized image resolutions of 4 × 4 × 4 mm3 [8]. However, a direct quantification of the signal in terms of local cell abundance is difficult due to tracer/image acquisition timing and complex post-processed image reconstructions. The need for cost intensive specialized equipment (linear accelerator) and staff (chemist) might hamper the applicability of PET/MRI in clinical routine. The 19F principle easily works on the widely available CMR platform, with an image resolution (1.35 × 1.35.1.5 mm3) sufficient for imaging inflammatory foci in the AMI border zone with a directly quantifiable signal, without the need for additional specialized equipment and personnel.
With the present CMR approach, the images of monocyte/macrophage infiltration were generated in vivo with a resolution and acquisition time comparable to clinical standard sequences and protocols (supplemental Table I). The pig model of reperfused AMI in the present study exhibited a similar extent of IS and frequency of MVO or IMH as typical patients with an anterior STEMI [6, 29]. Moreover, the monocyte/macrophage density was comparable to histopathological studies in patients [42], rendering the present model suitable for translational perspectives. Thus, 19F-CMR is a highly promising imaging technique for clinical trials aiming to further evaluate the effects on monocyte/macrophage infiltration in patients early after AMI.
Inflammatory infiltration and remote myocardial contractile function and initial left ventricular remodeling
In vivo myocardial 19F-signals revealed not only considerable inter-individual variation, which correlated to the systemic increase in leukocytes (supplemental figure IIID), but also a patchy appearance in myocardial infarction, which was validated by histology (Fig. 3). The spatial heterogeneity of monocytes/macrophage infiltration was reflected in features of the 19F-signal: Even those pigs with low 19F whole heart volumes (< 5 ml) had a mean myocardial 19F-SNR of > 10, indicating hot spots of monocyte/macrophage infiltration as known also from human autopsy studies [42]. The area of myocardial edema and IS was not entirely invaded by monocytes/macrophages as evidenced by 19F-CMR. Moreover, the incidence of MVO and IMH was even reduced in segments positive for 19F-CMR. Since MVO and IMH coincided in our model (day 6 after AMI), in good agreement to clinical observations [29], the attenuating effect of MVO on monocyte/magrophage infiltration, which has already been shown by other groups [45], might have counterbalanced the pro-inflammatory effect of IMH at day 6 [2].
Our present study provided novel information on the regional relationship between monocyte/macrophage infiltration in the infarct border zone with systolic wall thickening in the adjacent remote viable myocardium (Fig. 6A + B) and with LV remodeling early after AMI (Fig. 6G + H). The infarct border zone derived 19F-signal correlated inversely with remote myocardial systolic wall thickening. On histology, TNF-α was identified in remote cardiomyocytes (Fig. 6F). A spillover of cytokines with a negative inotropic action such as TNF-α from the border zone into the remote myocardium might thus explain the impaired wall thickening possibly mimicking stunned myocardium [17]. It is unclear to what extent such increased TNF-α levels are derived from monocytes/macrophages or the cardiomyocytes in the inflamed border zone, as shown in microembolized myocardium [7, 18].
On the level of a global analysis over the entire heart, the global 19F integral was associated with LV remodeling on univariate analysis. In multivariate analysis, the correlation of the global 19F integral was independent from edema, IS, MVO, and IMH, respectively. The greater the monocytes/macrophages infiltration, as indicated by 19F-CMR, the more enlarged was EDV. Our data revealed threshold values: when the 19F-derived monocyte/macrophage signal exceeded 200 SNR × ml over the entire heart, it was associated with LV remodeling; when the border zone 19F SNR exceeded 8, it was associated with impaired remote myocardial wall thickening.
Clinical perspectives and considerations
PFOB nanoemulsions have already been evaluated in clinical phase III studies as blood substitutes with similar application doses as used in the present study [35]. They are taken up by monocytes or macrophages irrespectively of their M1/M2 polarization in a time-dependent manner, while preserving their function [13, 26], which opens the translational perspective to develop 19F-based CMR imaging for future clinical applications. Due to the preferential uptake of PFOB nanoemulsions, 19F-based monocyte/macrophage imaging is rather cell-specific and directly quantifiable, as shown in the present study, and it might be even capable of being more specific when using functionalized nanoemulsions [11]. Intravenous administration of the nanoemulsion on day 3 after AMI enabled sufficient accumulation in monocytes/macrophages for sensitive detection by 19F-CMR within the infarcted myocardium on day 6 and was not associated with major side effects. Thus, 19F-CMR is capable to deliver in vivo information about early inflammatory infiltration after AMI. Inflammation can thus be visualized and followed as a potential additional target for subacute cardioprotection after AMI—beyond the already well established concept of preservation of coronary microcirculation [16].
Inflammation is a driver of adverse LV remodeling after AMI [44]. There are large inter-individual differences with respect to monocyte/macrophage quantity and localization in post-AMI inflammation [42]. The peri-infarct border zone, as identified by the specific gadolinium contrast agent uptake kinetics, is characterized by inflammatory infiltration, involved in the pathogenesis of arrhythmias [40] and associated with mortality [20].
For patients after AMI, it is currently unclear whether local hot spots of inflammation, a patchy pattern of inflammation in the infarct border, or the overall inflammatory volume in the heart drive clinical endpoints. The 19F platform might add novel information in this respect, since it specifically images monocytes/macrophages and thus can also monitor specific modulation of the inflammatory response by pharmacotherapy [21, 22, 28]. Compared to techniques using radiotracers, CMR is widely available and has better spatial resolution. In the future, the nanoemulsion delivery and the imaging workflow can easily be adopted to the management of patients after AMI in the hospital.
1H CMR-derived tissue markers for improved prediction of cardiovascular endpoints are not always present after AMI. Major markers of mortality after AMI, such as MVO and IMH, appear in only 40% of all patients. The 19F signal will most probably be detectable in every singular individual myocardium post-AMI within the infarct region and border zone, thus enabling quantification of inflammatory patterns and extent. For patients after AMI, it is currently unclear whether local hot spots of inflammation, a patchy pattern of inflammation in the infarct border, or the overall inflammatory volume in the heart drive clinical endpoints. The 19F platform might add novel information in this respect, since it specifically images monocytes/macrophages and thus can also monitor specific modulation of the inflammatory response by pharmacotherapy [22]. However, whether or not these additional information further enhance the risk prediction after AMI needs to be tested in clinical trials.
Study limitations
Since the present study aimed to mimic a clinical imaging scenario at day 6 with subsequent histological validation, the predictive value of the respective 1H- or 19F-derived signals on more long-term remodeling remains unclear. In mice, increased 19F-derived monocyte/macrophage signals predicted worsening of LV function also 28 days after AMI [3]. The time point of CMR analysis at 6 days post-AMI was chosen in line with recent expert consensus regarding the dynamic nature of infarct development and repair [19]. Our imaging study does not establish a cause-effect relationship between early inflammatory infiltration and impaired remote contractile function or LV remodeling early after reperfused AMI, but demonstrates a close association.
Conclusion
In vivo 19F-CMR provides noninvasive visualization and quantification of monocytes/macrophages with reliable sensitivity and spatial resolution. In the present study using a pig model of reperfused AMI, in vivo 19F-CM identifed inflammatory infiltration as independent determinant of LV contractile function and geometry early after acute myocardial infarction. In a translational perspective, in vivo 19F-CMmight also enable loco-regional and longitudinal cell-specific CMR based imaging in AMI patients on a widely available technological platform. Thus, 19F-CMR, in addition to established 1H-based CMR, offers the potential to identify and characterize targets for novel anti-inflammatory therapeutic agents.
Supplementary Information
Below is the link to the electronic supplementary material.
Acknowledgements
We thank Juliane Geisler, Moritz Walz, Lilian Vornholz, Sebastian Temme, Christoph Jacoby, Ganna Aleshcheva, Susanne Ochmann, Martin Sager, Georg Wolff and Elric Zweck for their excellent technical and administrative support. This study was supported by the German Research Foundation SFB 1116 Grant no. 236177352-projects B12 (M.R., M.K.), B08 (G.H.), B10 (U.F.), Gerok Scholarship (F.N.), and TRR 259 Grant no. 397484323 project B3 (F.B., U.F.), as well as project grants BO 4264/1-1 (F.B.), and FL303/6-1 (U.F.).
Funding
Open Access funding enabled and organized by Projekt DEAL.
Declarations
Conflict of interest
The authors declare that they have nothing to disclose. The authors declare that they have no conflict of interest.
Footnotes
H. Thiele, Leipzig, Germany, served as guest editor for the manuscript and was responsible for all editorial decisions, including the selection of reviewers. The policy applies to all manuscripts with authors from the editor’s institution.
References
- 1.Ambale-Venkatesh B, Yoneyama K, Sharma RK, Ohyama Y, Wu CO, Burke GL, Shea S, Gomes AS, Young AA, Bluemke DA, Lima JA. Left ventricular shape predicts different types of cardiovascular events in the general population. Heart. 2017;103:499–507. doi: 10.1136/heartjnl-2016-310052. [DOI] [PubMed] [Google Scholar]
- 2.Assimopoulos S, Shie N, Ramanan V, Qi X, Barry J, Strauss BH, Wright GA, Ghugre NR. Hemorrhage promotes chronic adverse remodeling in acute myocardial infarction: a T1, T2 and BOLD study. NMR Biomed. 2021;34:e4404. doi: 10.1002/nbm.4404. [DOI] [PubMed] [Google Scholar]
- 3.Bonner F, Jacoby C, Temme S, Borg N, Ding Z, Schrader J, Flogel U. Multifunctional MR monitoring of the healing process after myocardial infarction. Basic Res Cardiol. 2014;109:430. doi: 10.1007/s00395-014-0430-0. [DOI] [PubMed] [Google Scholar]
- 4.Bonner F, Merx MW, Klingel K, Begovatz P, Flogel U, Sager M, Temme S, Jacoby C, Salehi Ravesh M, Grapentin C, Schubert R, Bunke J, Roden M, Kelm M, Schrader J. Monocyte imaging after myocardial infarction with 19F MRI at 3 T: a pilot study in explanted porcine hearts. Eur Heart J Cardiovasc Imaging. 2015;16:612–620. doi: 10.1093/ehjci/jev008. [DOI] [PubMed] [Google Scholar]
- 5.Chowdhury MM, Tarkin JM, Albaghdadi MS, Evans NR, Le EPV, Berrett TB, Sadat U, Joshi FR, Warburton EA, Buscombe JR, Hayes PD, Dweck MR, Newby DE, Rudd JHF, Coughlin PA. Vascular positron emission tomography and restenosis in symptomatic peripheral arterial disease: a prospective clinical study. JACC Cardiovasc Imaging. 2020;13:1008–1017. doi: 10.1016/j.jcmg.2019.03.031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.de Waha S, Patel MR, Granger CB, Ohman EM, Maehara A, Eitel I, Ben-Yehuda O, Jenkins P, Thiele H, Stone GW. Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials. Eur Heart J. 2017;38:3502–3510. doi: 10.1093/eurheartj/ehx414. [DOI] [PubMed] [Google Scholar]
- 7.Dorge H, Schulz R, Belosjorow S, Post H, van de Sand A, Konietzka I, Frede S, Hartung T, Vinten-Johansen J, Youker KA, Entman ML, Erbel R, Heusch G. Coronary microembolization: the role of TNF-alpha in contractile dysfunction. J Mol Cell Cardiol. 2002;34:51–62. doi: 10.1006/jmcc.2001.1489. [DOI] [PubMed] [Google Scholar]
- 8.Fernandez-Friera L, Fuster V, Lopez-Melgar B, Oliva B, Sanchez-Gonzalez J, Macias A, Perez-Asenjo B, Zamudio D, Alonso-Farto JC, Espana S, Mendiguren J, Bueno H, Garcia-Ruiz JM, Ibanez B, Fernandez-Ortiz A, Sanz J. Vascular inflammation in subclinical atherosclerosis detected by hybrid PET/MRI. J Am Coll Cardiol. 2019;73:1371–1382. doi: 10.1016/j.jacc.2018.12.075. [DOI] [PubMed] [Google Scholar]
- 9.Fernandez-Jimenez R, Galan-Arriola C, Sanchez-Gonzalez J, Aguero J, Lopez-Martin GJ, Gomez-Talavera S, Garcia-Prieto J, Benn A, Molina-Iracheta A, Barreiro-Perez M, Martin-Garcia A, Garcia-Lunar I, Pizarro G, Sanz J, Sanchez PL, Fuster V, Ibanez B. Effect of ischemia duration and protective interventions on the temporal dynamics of tissue composition after myocardial infarction. Circ Res. 2017;121:439–450. doi: 10.1161/CIRCRESAHA.117.310901. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Flogel U, Ding Z, Hardung H, Jander S, Reichmann G, Jacoby C, Schubert R, Schrader J. In vivo monitoring of inflammation after cardiac and cerebral ischemia by fluorine magnetic resonance imaging. Circulation. 2008;118:140–148. doi: 10.1161/CIRCULATIONAHA.107.737890. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Flogel U, Temme S, Jacoby C, Oerther T, Keul P, Flocke V, Wang X, Bonner F, Nienhaus F, Peter K, Schrader J, Grandoch M, Kelm M, Levkau B. Multi-targeted (1)H/(19)F MRI unmasks specific danger patterns for emerging cardiovascular disorders. Nat Commun. 2021;12:5847. doi: 10.1038/s41467-021-26146-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Garcia-Prieto J, Villena-Gutierrez R, Gomez M, Bernardo E, Pun-Garcia A, Garcia-Lunar I, Crainiciuc G, Fernandez-Jimenez R, Sreeramkumar V, Bourio-Martinez R, Garcia-Ruiz JM, Del Valle AS, Sanz-Rosa D, Pizarro G, Fernandez-Ortiz A, Hidalgo A, Fuster V, Ibanez B. Neutrophil stunning by metoprolol reduces infarct size. Nat Commun. 2017;8:14780. doi: 10.1038/ncomms14780. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Garello F, Boido M, Miglietti M, Bitonto V, Zenzola M, Filippi M, Arena F, Consolino L, Ghibaudi M, Terreno E. Imaging of inflammation in spinal cord injury: novel insights on the usage of PFC-based contrast agents. Biomedicines. 2021 doi: 10.3390/biomedicines9040379. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Heimerl M, Sieve I, Ricke-Hoch M, Erschow S, Battmer K, Scherr M, Hilfiker-Kleiner D. Neuraminidase-1 promotes heart failure after ischemia/reperfusion injury by affecting cardiomyocytes and invading monocytes/macrophages. Basic Res Cardiol. 2020;115:62. doi: 10.1007/s00395-020-00821-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Heusch G. Coronary microvascular obstruction: the new frontier in cardioprotection. Basic Res Cardiol. 2019;114:45. doi: 10.1007/s00395-019-0756-8. [DOI] [PubMed] [Google Scholar]
- 16.Heusch G. Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nat Rev Cardiol. 2020;17:773–789. doi: 10.1038/s41569-020-0403-y. [DOI] [PubMed] [Google Scholar]
- 17.Heusch G. Myocardial stunning and hibernation revisited. Nat Rev Cardiol. 2021;18:522–536. doi: 10.1038/s41569-021-00506-7. [DOI] [PubMed] [Google Scholar]
- 18.Heusch G, Skyschally A, Schulz R. The in-situ pig heart with regional ischemia/reperfusion - ready for translation. J Mol Cell Cardiol. 2011;50:951–963. doi: 10.1016/j.yjmcc.2011.02.016. [DOI] [PubMed] [Google Scholar]
- 19.Ibanez B, Aletras AH, Arai AE, Arheden H, Bax J, Berry C, Bucciarelli-Ducci C, Croisille P, Dall'Armellina E, Dharmakumar R, Eitel I, Fernandez-Jimenez R, Friedrich MG, Garcia-Dorado D, Hausenloy DJ, Kim RJ, Kozerke S, Kramer CM, Salerno M, Sanchez-Gonzalez J, Sanz J, Fuster V. Cardiac MRI endpoints in myocardial infarction experimental and clinical trials: JACC scientific expert panel. J Am Coll Cardiol. 2019;74:238–256. doi: 10.1016/j.jacc.2019.05.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Jensch PJ, Stiermaier T, Reinstadler SJ, Feistritzer HJ, Desch S, Fuernau G, de Waha-Thiele S, Thiele H, Eitel I. Prognostic relevance of peri-infarct zone measured by cardiovascular magnetic resonance in patients with ST-segment elevation myocardial infarction. Int J Cardiol. 2022;347:83–88. doi: 10.1016/j.ijcard.2021.11.017. [DOI] [PubMed] [Google Scholar]
- 21.Jiao J, He S, Wang Y, Lu Y, Gu M, Li D, Tang T, Nie S, Zhang M, Lv B, Li J, Xia N, Cheng X. Regulatory B cells improve ventricular remodeling after myocardial infarction by modulating monocyte migration. Basic Res Cardiol. 2021;116:46. doi: 10.1007/s00395-021-00886-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Klingenberg R, Stahli BE, Heg D, Denegri A, Manka R, Kapos I, von Eckardstein A, Carballo D, Hamm CW, Vietheer J, Rolf A, Landmesser U, Mach F, Moccetti T, Jung C, Kelm M, Munzel T, Pedrazzini G, Raber L, Windecker S, Matter CM, Ruschitzka F, Luscher TF. Controlled-level EVERolimus in acute coronary syndrome (CLEVER-ACS)—a phase II, randomized, double-blind, multi-center, placebo-controlled trial. Am Heart J. 2022;247:33–41. doi: 10.1016/j.ahj.2022.01.010. [DOI] [PubMed] [Google Scholar]
- 23.Lewis AJM, Miller JJ, Lau AZ, Curtis MK, Rider OJ, Choudhury RP, Neubauer S, Cunningham CH, Carr CA, Tyler DJ. Noninvasive immunometabolic cardiac inflammation imaging using hyperpolarized magnetic resonance. Circ Res. 2018;122:1084–1093. doi: 10.1161/CIRCRESAHA.117.312535. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Nensa F, Poeppel T, Tezgah E, Heusch P, Nassenstein K, Mahabadi AA, Forsting M, Bockisch A, Erbel R, Heusch G, Schlosser T. Integrated FDG PET/MR imaging for the assessment of myocardial salvage in reperfused acute myocardial infarction. Radiology. 2015;276:400–407. doi: 10.1148/radiol.2015140564. [DOI] [PubMed] [Google Scholar]
- 25.Niccoli G, Montone RA, Ibanez B, Thiele H, Crea F, Heusch G, Bulluck H, Hausenloy DJ, Berry C, Stiermaier T, Camici PG, Eitel I. Optimized treatment of ST-elevation myocardial infarction. Circ Res. 2019;125:245–258. doi: 10.1161/CIRCRESAHA.119.315344. [DOI] [PubMed] [Google Scholar]
- 26.Nienhaus F, Colley D, Jahn A, Pfeiler S, Flocke V, Temme S, Kelm M, Gerdes N, Flogel U, Bonner F. Phagocytosis of a PFOB-nanoemulsion for (19)F magnetic resonance imaging: first results in monocytes of patients with stable coronary artery disease and ST-elevation myocardial infarction. Molecules. 2019 doi: 10.3390/molecules24112058. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Pawlowsky K, Ernst L, Steitz J, Stopinski T, Kogel B, Henger A, Kluge R, Tolba R. The Aachen Minipig: phenotype, genotype, hematological and biochemical characterization, and comparison to the Gottingen Minipig. Eur Surg Res. 2017;58:193–203. doi: 10.1159/000471483. [DOI] [PubMed] [Google Scholar]
- 28.Pearce L, Davidson SM, Yellon DM. Does remote ischaemic conditioning reduce inflammation? A focus on innate immunity and cytokine response. Basic Res Cardiol. 2021;116:12. doi: 10.1007/s00395-021-00852-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Reinstadler SJ, Stiermaier T, Reindl M, Feistritzer HJ, Fuernau G, Eitel C, Desch S, Klug G, Thiele H, Metzler B, Eitel I. Intramyocardial haemorrhage and prognosis after ST-elevation myocardial infarction. Eur Heart J Cardiovasc Imaging. 2019;20:138–146. doi: 10.1093/ehjci/jey101. [DOI] [PubMed] [Google Scholar]
- 30.Reiter T, Kircher M, Schirbel A, Werner RA, Kropf S, Ertl G, Buck AK, Wester HJ, Bauer WR, Lapa C. Imaging of C-X-C motif chemokine receptor CXCR4 expression after myocardial infarction with [(68)Ga]Pentixafor-PET/CT in correlation with cardiac MRI. JACC Cardiovasc Imaging. 2018;11:1541–1543. doi: 10.1016/j.jcmg.2018.01.001. [DOI] [PubMed] [Google Scholar]
- 31.Rischpler C, Dirschinger RJ, Nekolla SG, Kossmann H, Nicolosi S, Hanus F, van Marwick S, Kunze KP, Meinicke A, Gotze K, Kastrati A, Langwieser N, Ibrahim T, Nahrendorf M, Schwaiger M, Laugwitz KL. Prospective evaluation of 18F-fluorodeoxyglucose uptake in postischemic myocardium by simultaneous positron emission tomography/magnetic resonance imaging as a prognostic marker of functional outcome. Circ Cardiovasc Imaging. 2016;9:e004316. doi: 10.1161/CIRCIMAGING.115.004316. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Rischpler C, Nekolla SG, Heusch G, Umutlu L, Rassaf T, Heusch P, Herrmann K, Nensa F. Cardiac PET/MRI-an update. Eur J Hybrid Imaging. 2019;3:2. doi: 10.1186/s41824-018-0050-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Rothe M, Jahn A, Weiss K, Hwang JH, Szendroedi J, Kelm M, Schrader J, Roden M, Flogel U, Bonner F. In vivo (19)F MR inflammation imaging after myocardial infarction in a large animal model at 3 T. MAGMA. 2019;32:5–13. doi: 10.1007/s10334-018-0714-8. [DOI] [PubMed] [Google Scholar]
- 34.Schulz-Menger J, Bluemke DA, Bremerich J, Flamm SD, Fogel MA, Friedrich MG, Kim RJ, von Knobelsdorff-Brenkenhoff F, Kramer CM, Pennell DJ, Plein S, Nagel E. Standardized image interpretation and post-processing in cardiovascular magnetic resonance—2020 update: Society for Cardiovascular Magnetic Resonance (SCMR): Board of Trustees Task Force on Standardized Post-Processing. J Cardiovasc Magn Reson. 2020;22:19. doi: 10.1186/s12968-020-00610-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Spahn DR, Waschke KF, Standl T, Motsch J, Van Huynegem L, Welte M, Gombotz H, Coriat P, Verkh L, Faithfull S, Keipert P, European Perflubron Emulsion in Non-Cardiac Surgery Study G Use of perflubron emulsion to decrease allogeneic blood transfusion in high-blood-loss non-cardiac surgery: results of a European phase 3 study. Anesthesiology. 2002;97:1338–1349. doi: 10.1097/00000542-200212000-00004. [DOI] [PubMed] [Google Scholar]
- 36.Stone GW, Selker HP, Thiele H, Patel MR, Udelson JE, Ohman EM, Maehara A, Eitel I, Granger CB, Jenkins PL, Nichols M, Ben-Yehuda O. Relationship between infarct size and outcomes following primary PCI: patient-level analysis from 10 randomized trials. J Am Coll Cardiol. 2016;67:1674–1683. doi: 10.1016/j.jacc.2016.01.069. [DOI] [PubMed] [Google Scholar]
- 37.Swirski FK, Nahrendorf M. Cardioimmunology: the immune system in cardiac homeostasis and disease. Nat Rev Immunol. 2018;18:733–744. doi: 10.1038/s41577-018-0065-8. [DOI] [PubMed] [Google Scholar]
- 38.Tardif JC, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP, Pinto FJ, Ibrahim R, Gamra H, Kiwan GS, Berry C, Lopez-Sendon J, Ostadal P, Koenig W, Angoulvant D, Gregoire JC, Lavoie MA, Dube MP, Rhainds D, Provencher M, Blondeau L, Orfanos A, L'Allier PL, Guertin MC, Roubille F. Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med. 2019;381:2497–2505. doi: 10.1056/NEJMoa1912388. [DOI] [PubMed] [Google Scholar]
- 39.Tarkin JM, Calcagno C, Dweck MR, Evans NR, Chowdhury MM, Gopalan D, Newby DE, Fayad ZA, Bennett MR, Rudd JHF. (68)Ga-DOTATATE PET identifies residual myocardial inflammation and bone marrow activation after myocardial infarction. J Am Coll Cardiol. 2019;73:2489–2491. doi: 10.1016/j.jacc.2019.02.052. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Tulumen E, Rudic B, Ringlage H, Hohneck A, Roger S, Liebe V, Kuschyk J, Overhoff D, Budjan J, Akin I, Borggrefe M, Papavassiliu T. Extent of peri-infarct scar on late gadolinium enhancement cardiac magnetic resonance imaging and outcome in patients with ischemic cardiomyopathy. Heart Rhythm. 2021;18:954–961. doi: 10.1016/j.hrthm.2021.01.023. [DOI] [PubMed] [Google Scholar]
- 41.van der Bijl P, Abou R, Goedemans L, Gersh BJ, Holmes DR, Jr, Ajmone Marsan N, Delgado V, Bax JJ. Left ventricular post-infarct remodeling: implications for systolic function improvement and outcomes in the modern era. JACC Heart Fail. 2020;8:131–140. doi: 10.1016/j.jchf.2019.08.014. [DOI] [PubMed] [Google Scholar]
- 42.van der Laan AM, Ter Horst EN, Delewi R, Begieneman MP, Krijnen PA, Hirsch A, Lavaei M, Nahrendorf M, Horrevoets AJ, Niessen HW, Piek JJ. Monocyte subset accumulation in the human heart following acute myocardial infarction and the role of the spleen as monocyte reservoir. Eur Heart J. 2014;35:376–385. doi: 10.1093/eurheartj/eht331. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Cheng S, Delling FN, Elkind MSV, Evenson KR, Ferguson JF, Gupta DK, Khan SS, Kissela BM, Knutson KL, Lee CD, Lewis TT, Liu J, Loop MS, Lutsey PL, Ma J, Mackey J, Martin SS, Matchar DB, Mussolino ME, Navaneethan SD, Perak AM, Roth GA, Samad Z, Satou GM, Schroeder EB, Shah SH, Shay CM, Stokes A, VanWagner LB, Wang NY, Tsao CW, American Heart Association Council on E, Prevention Statistics C, Stroke Statistics S Heart disease and stroke statistics-2021 update: a report from the American Heart Association. Circulation. 2021;143:e254–e743. doi: 10.1161/CIR.0000000000000950. [DOI] [PubMed] [Google Scholar]
- 44.Westman PC, Lipinski MJ, Luger D, Waksman R, Bonow RO, Wu E, Epstein SE. Inflammation as a driver of adverse left ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol. 2016;67:2050–2060. doi: 10.1016/j.jacc.2016.01.073. [DOI] [PubMed] [Google Scholar]
- 45.Ye YX, Basse-Lusebrink TC, Arias-Loza PA, Kocoski V, Kampf T, Gan Q, Bauer E, Sparka S, Helluy X, Hu K, Hiller KH, Boivin-Jahns V, Jakob PM, Jahns R, Bauer WR. Monitoring of monocyte recruitment in reperfused myocardial infarction with intramyocardial hemorrhage and microvascular obstruction by combined fluorine 19 and proton cardiac magnetic resonance imaging. Circulation. 2013;128:1878–1888. doi: 10.1161/CIRCULATIONAHA.113.000731. [DOI] [PubMed] [Google Scholar]
- 46.Yilmaz A, Dengler MA, van der Kuip H, Yildiz H, Rosch S, Klumpp S, Klingel K, Kandolf R, Helluy X, Hiller KH, Jakob PM, Sechtem U. Imaging of myocardial infarction using ultrasmall superparamagnetic iron oxide nanoparticles: a human study using a multi-parametric cardiovascular magnetic resonance imaging approach. Eur Heart J. 2013;34:462–475. doi: 10.1093/eurheartj/ehs366. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.